Showing results (321-330 of 561) with videos related to
Sort By:
Pageof 57
Current Problems in Cancer|March 5, 2019
Pseudoprogression on treatment with immune-checkpoint inhibitors in patients with gastrointestinal malignancies: Case series and short literature reviewVasiliki Michalarea, Elisa Fontana, Alvaro Ingles Garces, et al.Annals of Hematology|October 26, 2013
GEM-P chemotherapy is active in the treatment of relapsed Hodgkin lymphomaEliza A Hawkes, Sarah Barton, David Cunningham, et al.Clinical Nuclear Medicine|March 6, 2015
The role of routine clinical pretreatment 18F-FDG PET/CT in predicting outcome of colorectal liver metastasisHenry H Tam, Gary J Cook, Ian Chau, et al.Clinical Colorectal Cancer|May 26, 2011
Correlation of overall survival with gene expression profiles in a prospective study of resectable esophageal cancerSheela Rao, Lyndsey Welsh, David Cunningham, et al.Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 15, 2014
Patient reported outcome measures for cardiac ablation procedures: a multicentre pilot to develop a new questionnaireKathleen L Withers, Judith White, Grace Carolan-Rees, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 28, 2023
Across-Country Variations of Real-World Data and Evidence for Drugs: A 5-European-Country StudyGérard de Pouvourville, David Cunningham, Frank-Ulrich Fricke, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 4, 2012
Three cytotoxic drugs combined with pelvic radiation and as maintenance chemotherapy for patients with squamous cell carcinoma of the anus (SCCA): long-term follow-up of a phase II pilot study using 5-fluorouracil, mitomycin C and cisplatinDavid Sebag-Montefiore, Helen M Meadows, David Cunningham, et al.The Lancet. Oncology|January 29, 2010
Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trialYu Jo Chua, Yolanda Barbachano, David Cunningham, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 20, 2024
Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652-3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal CancerSomaieh Hedayat, Luciano Cascione, David Cunningham, et al.Surgical Endoscopy|June 14, 2024
Introduction of day-case robotic liver surgery: a case series from a tertiary hepatobiliary and pancreatic centreKai Tai Derek Yeung, Rajendran Vellaisamy, Aasim Hussain, et al.Pageof 57